Editorial: The microbiome and gastric mucosal protection in aspirin users—Authors' reply
Publikation: Bidrag til tidsskrift › Leder › Forskning › fagfællebedømt
Standard
Editorial : The microbiome and gastric mucosal protection in aspirin users—Authors' reply. / Løn, Nina; Engel, Sara; Damholt, Anders; Wellejus, Anja; Knop, Filip K.
I: Alimentary Pharmacology and Therapeutics, Bind 59, Nr. 4, 2024, s. 577-578.Publikation: Bidrag til tidsskrift › Leder › Forskning › fagfællebedømt
Harvard
APA
Vancouver
Author
Bibtex
}
RIS
TY - JOUR
T1 - Editorial
T2 - The microbiome and gastric mucosal protection in aspirin users—Authors' reply
AU - Løn, Nina
AU - Engel, Sara
AU - Damholt, Anders
AU - Wellejus, Anja
AU - Knop, Filip K.
N1 - Funding Information: The author's declaration of personal and funding interests are unchanged from those in the original article.2
PY - 2024
Y1 - 2024
N2 - We thank Dr. Taha for his editorial on our article.1, 2 As discussed by Dr. Taha in a recent article for the British Society of Gastroenterology, the risk of NSAID-induced gastrointestinal damage should be addressed during long-term NSAID treatment, and we compliment Dr. Taha for emphasising the potential of a safe dietary supplement such as the probiotic strain Bifidobacterium breve Bif195 (DSM 33360), for aspirin users.3 We agree that alternative treatment strategies that may enable safe continuous NSAID treatment are warranted.
AB - We thank Dr. Taha for his editorial on our article.1, 2 As discussed by Dr. Taha in a recent article for the British Society of Gastroenterology, the risk of NSAID-induced gastrointestinal damage should be addressed during long-term NSAID treatment, and we compliment Dr. Taha for emphasising the potential of a safe dietary supplement such as the probiotic strain Bifidobacterium breve Bif195 (DSM 33360), for aspirin users.3 We agree that alternative treatment strategies that may enable safe continuous NSAID treatment are warranted.
U2 - 10.1111/apt.17826
DO - 10.1111/apt.17826
M3 - Editorial
C2 - 38247147
AN - SCOPUS:85182630736
VL - 59
SP - 577
EP - 578
JO - Alimentary Pharmacology and Therapeutics, Supplement
JF - Alimentary Pharmacology and Therapeutics, Supplement
SN - 0953-0673
IS - 4
ER -
ID: 381054169